Tumour-suppressive effects of curcumin analogs CCA-1.1 and Pentagamavunone-1 in colon cancer: In vivo and in vitro studies-Reference-Cited by-同舟云学术

Tumour-suppressive effects of curcumin analogs CCA-1.1 and Pentagamavunone-1 in colon cancer: In vivo and in vitro studies

Published:2023 Issue:4 Volume:14 Page:317
ISSN:2231-4040
Container-title:Journal of Advanced Pharmaceutical Technology & Research
language:en
Short-container-title:J Adv Pharm Technol Res

Author:

Meiyanto Edy,Wulandari Febri,Ikawati Muthi,Widyarini Sitarina,Kirihata Mitsunori,Novitasari Dhania,Kato Jun-ya

Publisher

Medknow

Subject

Pharmaceutical Science

Reference21 articles.

1. Curcumin analog pentagamavunon-1 (PGV-1) Sensitizes Widr cells to 5-fluorouracil through inhibition of NF-κB activation;Meiyanto;Asian Pac J Cancer Prev,2018

2. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence;Lestari;Sci Rep,2019

3. The target differences of anti-tumorigenesis potential of curcumin and its analogues against HER-2 positive and triple-negative breast cancer cells;Meiyanto;Adv Pharm Bull,2021

4. Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models;Kamitani;Sci Rep,2022

5. Preparation and cytotoxic evaluation of PGV-1 derivative, CCA-1.1, as a new curcumin analog with improved-physicochemical and pharmacological properties;Utomo;Adv Pharm Bull,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanism of Natural Food Antioxidants to Regulate ROS in Treating Cancer: A Review;Antioxidants;2024-02-06